gsk
aim
to
stop
aid
profit
one
of
the
world
largest
manufactur
of
hivaid
drug
ha
launch
an
initi
to
combat
the
smuggl
of
cheaper
pill
suppli
to
poorer
african
countri
back
into
europ
for
resal
at
far
higher
price
the
compani
glaxosmithklin
is
to
alter
the
packag
and
chang
the
colour
of
the
pill
current
provid
to
develop
nation
under
a
humanitarian
agreement
it
is
estim
that
drug
compani
are
lose
hundr
of
million
of
dollar
each
year
a
a
result
of
the
diver
of
their
product
in
thi
way
thi
is
a
veri
sensit
area
for
the
big
drug
compani
they
want
to
maintain
their
profit
but
have
been
put
under
tremend
pressur
to
provid
cheap
antiaid
drug
to
the
world
poorest
nation
the
result
is
that
drug
suppli
to
africa
are
now
more
than
thirti
time
cheaper
than
those
sold
in
europ
bring
these
medicin
within
the
reach
of
million
of
hivposit
african
through
their
govern
health
care
system
but
the
wide
differ
in
price
also
mean
that
there
are
big
gain
to
be
made
from
illeg
divert
these
cheaper
drug
back
into
wealthier
countri
and
resel
them
at
a
higher
price
glaxosmithklin
believ
that
by
coat
the
pill
destin
for
africa
in
a
red
dye
and
ad
new
identif
code
both
onto
the
pill
and
on
the
packag
then
thi
trade
can
be
substanti
reduc
the
compani
say
that
it
will
then
be
possibl
to
identifi
specif
distributor
in
africa
who
have
resold
humanitarian
drug
for
profit
a
well
a
those
supplier
in
europ
that
have
also
been
involv
in
the
trade
glaxo
say
distribut
of
the
newlook
drug
ha
alreadi
begun
and
that
their
chemic
content
is
ident
to
those
current
be
sold
in
europ
